Novavax 96.4% effective against original variant of COVID
Health
- 12 March, 2021
- 06:26
The Novavax coronavirus vaccine proved 96.4 percent effective against the original variant of coronavirus and 86.3 percent effective against its British strain, Report informs, referring to RIA Novosti.
The third phase of the NVX CoV2373 vaccine trial took place in the UK. The study covered more than 15,000 participants aged 18-84, 27 percent of them were over 65.
The company also said that when it comes to severe form of COVID, the vaccine has demonstrated 100 percent effectiveness.
Latest News
20:58
Germany welcomes growing economic interaction between Azerbaijan and Armenia
Foreign policy20:58
Estonia announces nearly €400,000 in humanitarian aid for Ukraine
Other countries20:49
Japan seeks to expand 'green' energy cooperation with Azerbaijan
Foreign policy20:41
Japanese ambassador: Tokyo shows strong interest in WUF13
Foreign policy20:31
US imposes sanctions on Iran's interior minister and other officials
Other countries20:15
President dismisses head of Garadagh district executive authority
Domestic policy20:07
President Ilham Aliyev signs order on awarding Presidential Prizes to Youth
Domestic policy20:02
Israel declares South African chargé d'affaires persona non grata
Other countries19:36
Photo